227 results on '"Shields, Adrian"'
Search Results
52. Outcomes Following SARS-CoV-2 Infection in Patients With Primary and Secondary Immunodeficiency in The United Kingdom
53. Infections in the immunocompromised host: primary immunodeficiency disorders
54. Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
55. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
56. A twist in the tale: epiploic appendagitis mimicking acute appendicitis
57. Strongyloides stercoralis hyperinfection presenting as subacute small bowel obstruction following immunosuppressive chemotherapy for multiple myeloma
58. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
59. Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre
60. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
61. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
62. Establishing the prevalence of common, clinically relevant tissue-specific autoantibodies following SARS CoV-2 infection
63. Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
64. Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
65. Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals
66. Health Care Professionals' Confidence and Preferences for Diagnostic Assays for SARS-CoV-2: A Global Study
67. T cell response to SARS-CoV-2 infection in humans: A systematic review
68. Longitudinal Protection Following Natural SARS-CoV-2 Infection and Early Vaccine Responses: Insights from a Cohort of Community Based Dental Health Care Professionals
69. T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study
70. Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine
71. Antibody response to SARS-CoV-2 infection in humans: A systematic review
72. Vitamin D status and seroconversion for COVID-19 in UK healthcare workers
73. Serology confirms SARS-CoV-2 infection in PCR-negative children with Paediatric Inflammatory Multi-System Syndrome
74. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
75. Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic
76. SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
77. Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns
78. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
79. Cellular immune response to SARS-CoV-2 infection in humans: a systematic review
80. Sensitive detection of SARS-CoV-2-specific-antibodies in dried blood spot samples
81. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
82. Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome
83. SARS-CoV-2 seroconversion in health care workers
84. In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser
85. Classical and Non-classical Presentations of Complement Factor I Deficiency: Two Contrasting Cases Diagnosed via Genetic and Genomic Methods
86. Additional file 1: Figure S1. of Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
87. Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
88. Effect of UBE2L3 genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus
89. UBE2L3 Polymorphism Amplifies NF-κB Activation and Promotes Plasma Cell Development, Linking Linear Ubiquitination to Multiple Autoimmune Diseases
90. RESOURCE UTILISATION ASSOCIATED WITH SINGLE DIGIT DUPUYTREN'S CONTRACTURE TREATED WITH EITHER SURGERY OR INJECTION OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
91. A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
92. Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID19 vaccine regimens: a longitudinal cohort study
93. Right ventricular metastasis of transitional cell carcinoma of the renal pelvis: successful single stage surgical treatment.
94. Antibody response to SARS-CoV-2 infection in humans: a systematic review
95. Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
96. Antibody response to SARS-CoV-2 infection in humans: A systematic review
97. Antibody response to SARS-CoV-2 infection in humans: A systematic review
98. Effect of UBE2L3genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus
99. TIMING IS THE KEY.
100. Vitamin D status and seroconversion for COVID-19 in UK healthcare workers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.